Dr. Stuart Cockerill
Chief Scientific Officer, Founder
Stuart was the Principal Investigator on a Wellcome Trust funded Project, on behalf of ReViral. He obtained his PhD in Organic Chemistry at the University of Leeds. After a Postdoctoral fellowship at Cornell University, he joined the GSK heritage company, the Wellcome Foundation and over the next 15 years led drug discovery projects in Pesticides, Immunology, Virology and Oncology. His key achievement was leading the erbB2 Oncology Project Team that discovered Tykerb™ for which Stuart is a named inventor. In December 2000, Stuart joined Arrow Therapeutics as Head of Chemistry and subsequently as Research Director. Stuart remained as Head of Arrow until the end of 2010. Stuart held the position of Senior Lecturer in Medicinal Chemistry at the University of Durham. His key achievements were two clinical Proof of Concept drug candidates involving novel approaches to the treatment of Respiratory Syncytial Virus and Hepatitis C Virus infection. Stuart is an author of over 70 papers, patents and book chapters.